insights_auto
Outlook: 75.0% bullish·0.0% bearish
Go to analysischevron_right
VRTX:NASDAQ
Vertex Pharmaceuticals Inc
$516.34
arrow_upward
+0.26%(+1.35) 1D
$516.34
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 23, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRTX...
Open
$515.60
High
$525.43
Low
$509.56
Mkt. cap
130.87B
Avg. vol.
1.05M
Volume
1.21M
P/E ratio
30.04
52-wk high
$560.25
52-wk low
$374.17
EPS
$17.19
Beta
0.32
Shares outstanding
253.46M
No. of employees
6K
Open
$515.60
High
$525.43
Low
$509.56
Mkt. cap
130.87B
Avg. vol.
1.05M
Volume
1.21M
P/E ratio
30.04
52-wk high
$560.25
52-wk low
$374.17
EPS
$17.19
Beta
0.32
Shares outstanding
253.46M
No. of employees
6K
News stories
From web sources and news partners
AD HOC NEWS
·
5 hours ago
Crinetics Pharmaceuticals stock exits Nasdaq after USD 85.00 deal
Zacks
·
6 hours ago
Vertex Posts Positive Phase II Data on Kidney Disease Drug
Zacks Investment Research
·
7 hours ago
Vertex Posts Positive Phase II Data on Kidney Disease Drug
Simply Wall Street
·
12 hours ago
Vertex Pharmaceuticals (VRTX) Reports Positive Phase 2b Inaxaplin Data In Kidney Disease
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc
CEOReshma Kewalramani
Employees6.4K
Founded1989
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitevrtx.com